Clinical Trial Update: Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating IL-1β inhibition to reduce inflammation and cardiovascular risk in people with HIV and cardiovascular disease; results posted after com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• HIV Infection

Snippet

Sponsor: Priscilla Hsue, MD | Conditions: HIV, Cardiovascular Disease | Phase 2 | Status: COMPLETED | Results posted: 2023-04-20